BlackRock
DOVA

BlackRock’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

BlackRock’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-987,298
Closed -$27.6M – 5149
2019
Q3 		$27.6M Sell
987,298
-11,824
-1% -$192K ﹤0.01% 2627
2019
Q2 		$14.1M Sell
999,122
-156,930
-14% -$1.49M ﹤0.01% 3045
2019
Q1 		$10.3M Buy
1,156,052
+4,217
+0.4% +$34.2K ﹤0.01% 3107
2018
Q4 		$8.73M Sell
1,151,835
-2,397
-0.2% -$38.6K ﹤0.01% 3164
2018
Q3 		$24.2M Buy
1,154,232
+9,312
+0.8% +$222K ﹤0.01% 2764
2018
Q2 		$34.3M Buy
1,144,920
+496,306
+77% +$13.5M ﹤0.01% 2567
2018
Q1 		$17.6M Buy
648,614
+71,815
+12% +$2.15M ﹤0.01% 2841
2017
Q4 		$16.6M Buy
576,799
+348,290
+152% +$9.55M ﹤0.01% 2876
2017
Q3 		$5.55M Buy
+228,509
New +$5.42M ﹤0.01% 3439

BlackRock's DOVA Position: Q4 2019 in Review

BlackRock sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 987,298 shares — an estimated $27.6M sold.

BlackRock first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $34.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • BlackRock reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • BlackRock sold 987,298 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $27.6M.
  • BlackRock first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • BlackRock's Dova Pharmaceuticals, Inc. Common Stock position peaked at $34.3M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.